Treatment Options for Erectile Dysfunction
The first-line treatment for erectile dysfunction should be oral phosphodiesterase type 5 (PDE5) inhibitors, unless contraindicated, with treatment options applied in a stepwise fashion balancing invasiveness and risk against efficacy. 1, 2
Initial Assessment and Risk Factors
Before initiating treatment, consider:
- Cardiovascular risk assessment (especially important as ED may be an early marker of cardiovascular disease)
- Medication review (many drugs can cause ED, including antihypertensives and psychotherapeutic drugs) 3
- Hormonal evaluation in select cases (testosterone levels)
- Lifestyle factors (obesity, smoking, alcohol consumption, physical inactivity)
Treatment Algorithm
First-Line Therapy: PDE5 Inhibitors
PDE5 inhibitors have success rates of 60-65% across various patient populations 2:
- Sildenafil: Take 60 minutes before sexual activity
- Tadalafil: Available as needed or daily dosing (2.5-5mg); effective for up to 24 hours 4
- Vardenafil: Higher selectivity compared to sildenafil
- Avanafil: Newer agent with similar efficacy profile
Important precautions:
- Absolute contraindication: Concurrent use of nitrates due to risk of severe hypotension 2, 4
- Cardiovascular risk stratification required before initiating therapy
- Sexual activity represents moderate physical exertion (2.0-5.4 METs)
Second-Line Therapies
If PDE5 inhibitors fail or are contraindicated:
Intraurethral alprostadil suppositories:
- Effective alternative when oral therapy fails
Intracavernous injection therapy:
- Using vasodilator drugs like alprostadil
- Success rates up to 90%, but higher attrition due to personal inconvenience 5
- Requires proper training for self-administration
Vacuum constriction devices:
- Non-invasive mechanical option
- Effective but may reduce spontaneity 2
Third-Line Therapy
Penile prosthesis implantation:
- Reserved for patients who fail or cannot use other therapies
- High satisfaction rates but invasive surgical procedure 6
- Modern implants have reduced infection rates and mechanical failures 5
Adjunctive Approaches
Lifestyle modifications:
- Smoking cessation
- Limiting alcohol consumption
- Regular physical activity
- Weight loss
- These can improve both ED and cardiovascular health 2
Psychosexual therapy:
- Useful in combination with medical treatments
- Particularly valuable for ED with psychological components
- Cognitive-behavioral therapy has 50-80% success rates for predominantly psychogenic ED 2
Medication adjustments:
- Consider alternative medications with lower risk of causing ED
- Common culprits include thiazide diuretics, beta-blockers, and SSRI antidepressants 3
Special Populations
- Diabetic patients: PDE5 inhibitors effective but may require more aggressive dosing 2
- Post-prostate cancer treatment: ED is common; validated tools like SHIM should monitor erectile function 2
- Testosterone deficiency: Consider replacement therapy only if confirmed (<300 ng/dL with symptoms) 2
Treatment Monitoring
- Follow-up evaluation to assess treatment efficacy
- Consider switching between different PDE5 inhibitors if initial response is suboptimal
- For daily tadalafil, start with 2.5mg, potentially increasing to 5mg if tolerated 2
- Ensure availability of treatment for priapism when initiating medical therapies 2
Emerging Therapies
Newer approaches showing promise include:
- Low-intensity extracorporeal shock wave therapy
- Stem cell injection therapy
- These aim to repair organic damage to the corpora cavernosa 7
The choice of treatment should be made jointly by the physician, patient, and when possible, the partner, considering patient preferences, expectations, and the physician's judgment 1.